Viridian Therapeutics, Inc./DE Revenue from Contract with Customer, Including Assessed Tax
Viridian Therapeutics, Inc./DE (VRDN) reported Revenue from Contract with Customer, Including Assessed Tax of $284.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2026-08-06
- Viridian Therapeutics, Inc./DE revenue from contract with customer, including assessed tax for the quarter ending 2026-06-30 was $284.00K, a 278.67% increase year-over-year.
- Viridian Therapeutics, Inc./DE revenue from contract with customer, including assessed tax for the quarter ending 2026-03-31 was $141.00K, a 95.83% increase year-over-year.
- Viridian Therapeutics, Inc./DE revenue from contract with customer, including assessed tax for the quarter ending 2025-12-31 was $132.00K, a 83.33% increase year-over-year.
- Viridian Therapeutics, Inc./DE revenue from contract with customer, including assessed tax for the quarter ending 2025-09-30 was $70.57M, a 81958.14% increase year-over-year.
- Viridian Therapeutics, Inc./DE revenue from contract with customer, including assessed tax for fiscal 2025 was $70.85M, a 23359.93% increase from fiscal 2024.
- Viridian Therapeutics, Inc./DE revenue from contract with customer, including assessed tax for fiscal 2024 was $302.00K, a 3.82% decline from fiscal 2023.
- Viridian Therapeutics, Inc./DE revenue from contract with customer, including assessed tax for fiscal 2023 was $314.00K, a 82.28% decline from fiscal 2022.
- Viridian Therapeutics, Inc./DE revenue from contract with customer, including assessed tax for fiscal 2022 was $1.77M, a 40.20% decline from fiscal 2021.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 6 month | Revenue from Contract with Customer, Including Assessed Tax 9 month | Revenue from Contract with Customer, Including Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $284.00K 10-Q · filed 2026-08-06 | $425.00K 10-Q · filed 2026-08-06 | $557.00K derived: sum of 3 quarters · filed 2026-08-06 | $71.13M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $141.00K 10-Q · filed 2026-05-05 | $273.00K derived: sum of 2 quarters · filed 2026-05-05 | $70.84M derived: sum of 3 quarters · filed 2026-05-05 | $70.92M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $132.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $70.70M derived: sum of 2 quarters · filed 2026-02-26 | $70.78M derived: sum of 3 quarters · filed 2026-08-06 | $70.85M 10-K · filed 2026-02-26 |
| 2025-09-30 | $70.57M 10-Q · filed 2025-11-05 | $70.64M derived: sum of 2 quarters · filed 2026-08-06 | $70.72M 10-Q · filed 2025-11-05 | $70.79M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $75.00K 10-Q · filed 2026-08-06 | $147.00K 10-Q · filed 2026-08-06 | $219.00K derived: sum of 3 quarters · filed 2026-08-06 | $305.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $72.00K 10-Q · filed 2026-05-05 | $144.00K derived: sum of 2 quarters · filed 2026-05-05 | $230.00K derived: sum of 3 quarters · filed 2026-05-05 | $302.00K derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $72.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $158.00K derived: sum of 2 quarters · filed 2026-02-26 | $230.00K derived: sum of 3 quarters · filed 2026-02-26 | $302.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $86.00K 10-Q · filed 2025-11-05 | $158.00K derived: sum of 2 quarters · filed 2025-11-05 | $230.00K 10-Q · filed 2025-11-05 | $302.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $72.00K 10-Q · filed 2025-08-06 | $144.00K 10-Q · filed 2025-08-06 | $216.00K derived: sum of 3 quarters · filed 2026-02-26 | $288.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $72.00K 10-Q · filed 2025-05-06 | $144.00K derived: sum of 2 quarters · filed 2026-02-26 | $216.00K derived: sum of 3 quarters · filed 2026-02-26 | $288.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $72.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $144.00K derived: sum of 2 quarters · filed 2026-02-26 | $216.00K derived: sum of 3 quarters · filed 2026-02-26 | $314.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $72.00K 10-Q · filed 2024-11-12 | $144.00K derived: sum of 2 quarters · filed 2024-11-12 | $242.00K 10-Q · filed 2024-11-12 | $347.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $72.00K 10-Q · filed 2024-08-08 | $170.00K 10-Q · filed 2024-08-08 | $275.00K derived: sum of 3 quarters · filed 2025-03-03 | $1.47M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $98.00K 10-Q · filed 2024-05-08 | $203.00K derived: sum of 2 quarters · filed 2025-03-03 | $1.40M derived: sum of 3 quarters · filed 2025-03-03 | $1.65M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $105.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $1.30M derived: sum of 2 quarters · filed 2025-03-03 | $1.56M derived: sum of 3 quarters · filed 2025-03-03 | $1.77M 10-K · filed 2025-03-03 |
| 2022-09-30 | $1.20M 10-Q · filed 2023-11-13 | $1.45M derived: sum of 2 quarters · filed 2023-11-13 | $1.67M 10-Q · filed 2023-11-13 | $1.88M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $256.00K 10-Q · filed 2023-08-08 | $472.00K 10-Q · filed 2023-08-08 | $686.00K derived: sum of 3 quarters · filed 2024-02-27 | $894.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $216.00K 10-Q · filed 2023-05-10 | $430.00K derived: sum of 2 quarters · filed 2024-02-27 | $638.00K derived: sum of 3 quarters · filed 2024-02-27 | $1.73M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $214.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $422.00K derived: sum of 2 quarters · filed 2024-02-27 | $1.51M derived: sum of 3 quarters · filed 2024-02-27 | $2.96M 10-K · filed 2024-02-27 |
| 2021-09-30 | $208.00K 10-Q · filed 2022-11-14 | $1.30M derived: sum of 2 quarters · filed 2022-11-14 | $2.75M 10-Q · filed 2022-11-14 | $2.80M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $1.09M 10-Q · filed 2022-08-15 | $2.54M 10-Q · filed 2022-08-15 | $2.60M derived: sum of 3 quarters · filed 2022-08-15 | $2.60M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $1.45M 10-Q · filed 2022-05-13 | $1.50M derived: sum of 2 quarters · filed 2022-05-13 | $1.50M derived: sum of 3 quarters · filed 2022-05-13 | $1.67M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $54.00K derived: sum of 2 quarters · filed 2022-03-11 | $222.00K derived: sum of 3 quarters · filed 2022-03-11 | $1.05M 10-K · filed 2022-03-11 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-05 | $168.00K derived: sum of 2 quarters · filed 2021-11-05 | $996.00K 10-Q · filed 2021-11-05 | $1.88M derived: sum of 4 quarters · filed 2021-11-05 |
| 2020-06-30 | $168.00K 10-Q · filed 2021-08-12 | $996.00K 10-Q · filed 2021-08-12 | $1.88M derived: sum of 3 quarters · filed 2021-08-12 | $2.57M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $828.00K 10-Q · filed 2021-05-07 | $1.71M derived: sum of 2 quarters · filed 2021-05-07 | $2.40M derived: sum of 3 quarters · filed 2021-05-07 | $4.92M derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-31 | $880.00K 10-K · filed 2020-03-13 | $1.57M derived: sum of 2 quarters · filed 2020-11-12 | $4.09M derived: sum of 3 quarters · filed 2020-11-12 | $4.46M 10-K · filed 2021-03-26 |
| 2019-09-30 | $695.00K 10-Q · filed 2020-11-12 | $3.21M derived: sum of 2 quarters · filed 2020-11-12 | $3.58M 10-Q · filed 2020-11-12 | $4.06M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $2.51M 10-Q · filed 2020-08-05 | $2.89M 10-Q · filed 2020-08-05 | $3.36M derived: sum of 3 quarters · filed 2020-08-05 | $4.31M derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | $372.00K 10-Q · filed 2020-05-08 | $848.00K derived: sum of 2 quarters · filed 2020-05-08 | $1.79M derived: sum of 3 quarters · filed 2020-05-08 | $3.97M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | $476.00K 10-K · filed 2020-03-13 | $1.42M derived: sum of 2 quarters · filed 2020-03-13 | $3.60M derived: sum of 3 quarters · filed 2020-03-13 | $8.39M 10-K · filed 2020-03-13 |
| 2018-09-30 | $944.00K 10-K · filed 2020-03-13 | $3.13M derived: sum of 2 quarters · filed 2020-03-13 | $7.91M 10-Q · filed 2019-11-08 | $9.10M derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-06-30 | $2.18M 10-K · filed 2020-03-13 | $6.97M 10-Q · filed 2019-08-08 | $8.16M derived: sum of 3 quarters · filed 2020-03-13 | $9.79M derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-03-31 | $4.78M 10-K · filed 2020-03-13 | $5.98M derived: sum of 2 quarters · filed 2020-03-13 | $7.61M derived: sum of 3 quarters · filed 2020-03-13 | $8.32M derived: sum of 4 quarters · filed 2020-03-13 |
| 2017-12-31 | $1.19M 10-K · filed 2019-03-14 | $2.82M derived: sum of 2 quarters · filed 2019-03-14 | $3.54M derived: sum of 3 quarters · filed 2019-03-14 | $4.00M 10-K · filed 2019-03-14 |
| 2017-09-30 | $1.63M 10-K · filed 2019-03-14 | $2.35M derived: sum of 2 quarters · filed 2019-03-14 | $2.81M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $718.00K 10-K · filed 2019-03-14 | $1.18M 10-Q · filed 2018-08-08 | ||
| 2017-03-31 | $462.00K 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |